Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000704147 | SCV000833085 | likely benign | Familial hypocalciuric hypercalcemia; Autosomal dominant hypocalcemia 1 | 2024-08-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004019782 | SCV001180008 | uncertain significance | Nephrolithiasis/nephrocalcinosis | 2022-10-20 | criteria provided, single submitter | clinical testing | The p.R1041W variant (also known as c.3121C>T), located in coding exon 6 of the CASR gene, results from a C to T substitution at nucleotide position 3121. The arginine at codon 1041 is replaced by tryptophan, an amino acid with dissimilar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Science for Life laboratory, |
RCV000149000 | SCV000088642 | unknown | Malignant tumor of prostate | no assertion criteria provided | not provided | Converted during submission to Uncertain significance. |